Mass Spectrometry

Overview

Mass spectrometry (MS) is an analytical technique that measures the mass-to-charge ratio (m/z) of charged particles. In peptide science, it serves as the primary method for confirming that a synthesized peptide has the correct molecular weight — essentially verifying that the peptide is what it claims to be.

While HPLC tells you how pure a sample is, mass spectrometry tells you what is in it. Together, these two techniques form the foundation of peptide quality control and are standard components of any Certificate of Analysis.

How Mass Spectrometry Works

All mass spectrometers share three fundamental components:

1. Ion Source

The sample must be converted to gas-phase ions. For peptides, two ionization methods dominate:

MALDI (Matrix-Assisted Laser Desorption/Ionization): The peptide sample is mixed with a UV-absorbing matrix compound and spotted onto a metal plate. A pulsed laser vaporizes and ionizes the sample. MALDI typically produces singly charged ions, making spectra straightforward to interpret.

ESI (Electrospray Ionization): The sample in solution is sprayed through a charged capillary, producing a fine mist of charged droplets that evaporate to yield gas-phase ions. ESI produces multiply charged ions, generating characteristic charge-state envelopes. ESI interfaces naturally with liquid chromatography (LC-MS), enabling simultaneous separation and identification.

2. Mass Analyzer

Separates ions based on their m/z ratio. Common types include:

• Time-of-flight (TOF) — Measures the time ions take to traverse a field-free region. Lighter ions arrive faster. Paired with MALDI as MALDI-TOF, this is the most common configuration for routine peptide identification.
• Quadrupole — Uses oscillating electric fields to selectively transmit ions of specific m/z values. Common in LC-MS systems.
• Ion trap — Captures ions in an electric field for sequential analysis. Enables tandem MS (MS/MS) for structural characterization.
• Orbitrap — Traps ions in an electrostatic field; provides very high mass accuracy and resolution. Increasingly used in peptide and proteomics research.

3. Detector

Converts ion impacts into electrical signals. The resulting data is displayed as a mass spectrum — a plot of signal intensity versus m/z ratio.

Interpreting Mass Spectrometry Data

Molecular Weight Confirmation

The primary use in peptide QC. The observed molecular weight is compared to the theoretical molecular weight calculated from the amino acid sequence:

• Match (within tolerance): The peptide has the expected molecular composition
• Mismatch: The sample may contain the wrong peptide, a modified form, or a different salt form

Typical mass accuracy for MALDI-TOF is +/- 0.01-0.1% (1-10 ppm for modern instruments). ESI-Orbitrap instruments achieve sub-1 ppm accuracy.

Common Mass Shifts

Charge States (ESI)

In ESI spectra, the same peptide appears as a series of peaks at different m/z values corresponding to different numbers of proton charges. For a peptide of molecular weight M:

• [M+H]+ appears at (M+1)/1
• [M+2H]2+ appears at (M+2)/2
• [M+3H]3+ appears at (M+3)/3

Software deconvolution converts these charge-state envelopes back to the neutral molecular weight.

Tandem Mass Spectrometry (MS/MS)

Tandem MS involves two stages of mass analysis. In the first stage, a specific ion is selected (precursor ion). This ion is then fragmented — typically by collision with an inert gas (collision-induced dissociation, CID). The resulting fragment ions are analyzed in the second stage.

For peptides, fragmentation occurs primarily along the peptide backbone, generating predictable ion series:

• b-ions — Fragments retaining the N-terminal portion
• y-ions — Fragments retaining the C-terminal portion

By reading the mass differences between consecutive fragments, the amino acid sequence can be determined. This is critical for:

• Confirming the exact sequence (not just molecular weight)
• Identifying post-translational modifications and their specific locations
• De novo sequencing of unknown peptides
• Distinguishing between isomeric peptides (same mass, different sequence)

Applications in Peptide Research

Quality Control

Every reputable peptide manufacturer includes MS data on their COA. At minimum, the observed molecular weight should match the theoretical value within instrument tolerance.

Stability Studies

MS can monitor peptide degradation by detecting oxidation, deamidation, hydrolysis, or other modifications that alter molecular weight over time.

Pharmacokinetic Studies

LC-MS/MS methods enable quantification of peptides in biological matrices (plasma, tissue) at nanogram or even picogram per milliliter concentrations, making it essential for bioavailability and pharmacokinetic research.

Proteomics

Large-scale identification of peptides and proteins in complex biological samples relies entirely on MS-based workflows, enabling discovery of new bioactive peptides and characterization of peptide processing pathways.

Limitations

• MS confirms molecular composition but not three-dimensional structure
• Isomeric amino acids (leucine and isoleucine, mass 113.08 Da) cannot be distinguished by standard MS or MS/MS
• Quantification requires calibration standards; peak intensity alone is not a reliable measure of abundance
• Sample preparation and ionization can introduce artifacts
• Cost and expertise requirements limit accessibility compared to HPLC

Despite these limitations, mass spectrometry remains an indispensable tool in peptide research and quality assurance, providing molecular-level identity verification that no other technique can match.